Minimally invasive radical hysterectomy is associated with significantly higher risks of recurrence and death vs open surgery in early-stage cervical cancer, according to a recent meta-analysis that lends support to the findings of a controversial trial.
Adding veliparib to a carboplatin-paclitaxel combination improved progression-free survival (PFS) in patients with BRCA1/2 hormone receptor-positive (HR+) or triple-negative breast cancer (TNBC), subgroup analysis of the phase III BROCADE3* trial showed.
Early initiation of solid food after caesarean delivery under regional anaesthesia does not result in more gastrointestinal complaints and even has high satisfaction in low-risk women, a recent study has shown.
Pregnant women with the coronavirus disease 2019 (COVID-19) appear to show higher rates of preterm birth and caesarean deliveries, according to a new meta-analysis. COVID-19 does not seem to substantially affect other pregnancy outcomes.
Treatment with Lactobacillus crispatus CTV-05 (Lactin-V) significantly reduces the incidence of bacterial vaginosis recurrence in women who were previously treated with vaginal metronidazole, according to a recent study.
The nonhormonal contraceptive copper intrauterine device (IUD) carries an increased hazard of bacterial vaginosis that remains elevated through up to 18 months of use but returns to pre-initiation levels following discontinuation, a study has found.
Implementation of the enhanced recovery after surgery (ERAS) protocols incorporating the use of scheduled multimodal analgesia reduced the need for opioid use in patients undergoing caesarean section (C-section), reveals a retrospective study presented at the ACOG 2020 Meeting.
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.
Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.